• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

New FDA warning for Tysabri

April 28, 2010  

Chronic cerebrospinal venous insufficiency (CCSVI)

February 16, 2010  

Assessing the nocebo effect in MS trials

January 5, 2010  

Pulsed methylprednisolone: MECOMBIN trial results

January 5, 2010  

Teriflunomide in combination with beta-IFN: preliminary results

January 5, 2010  

Cognitive impairment in adolescent MS: follow-up results

December 15, 2009  

Alemtuzumab in MS: 4-year follow-up

December 15, 2009  

Vitamin D in MS: update on new studies

December 15, 2009  

EBV: an association with MS?

November 3, 2009  

Smoking may increase risk of MS disease progression

October 20, 2009  
Previous
40
41
42
43
44
Next

Browse by Topic

  • MS (444)
  • CLINICAL CASES (22)
  • EAN 2026 (2)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Ofatumumab 2026 – update on real-world effectiveness posted on September 22, 2026
  • CLINICAL CASES IN NEUROLOGY – A YOUNG WOMAN WITH MILD EARLY MS posted on September 17, 2026
  • Highlights of EAN 2026 – Part 2 posted on July 9, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions